Defibrillator Market

7500+ companies worldwide approach us every year for their revenue growth initiatives

Global top 2000 strategist rely on us for their growth strategies.

80% of fortune 2000 companies rely on our research to identify new revenue sources.

30000 High Growth Opportunities

95% renewal rate

KNOW MORE

Defibrillator Market by Product (Tranvenous ICD (Single & dual chamber, biventricular, CRT-D), Subcutaneous, External (Automated, Wearable)), Patient (Adult, Pediatric), Enduser (Hospitals, Prehospital, Home care, Public Access) - Global Forecast to 2028

FREE BROCHURE FREE SAMPLE REPORT

Report Code: MD 3124 Jun, 2023, by marketsandmarkets.com

The global defibrillator market in terms of revenue was estimated to be worth $13.6 billion in 2023 and is poised to reach $18.1 billion by 2028, growing at a CAGR of 5.9% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth in this market is attributed to the increase in the prevalence of cardiovascular diseases, the increasing adult population with higher susceptibility to cardiac arrest, a strong focus of government organizations to enhance the accessibility of defibrillators by boosting the installation of public access defibrillators, and providing training & programs on defibrillators. Additionally, the rapid expansion of healthcare infrastructure in emerging countries and strategic collaborations & partnerships among manufacturers to boost the new developments in defibrillators is likely to support the market's growth in the near future.

Defibrillators Market

To know about the assumptions considered for the study, Request for Free Sample Report

Defibrillators Market

Defibrillator Market Dynamics

Driver: Growing prevalence of target diseases

Globally, a large proportion of the population is affected by cardiovascular diseases, such as coronary artery disease and cardiac arrest. The increasing prevalence of cardiovascular diseases is responsible for the rising number of deaths worldwide. According to the Centers for Disease Control and Prevention (CDC), around 695,000 deaths people in the US were attributed to CVD in 2021.

Moreover, coronary artery disease increases the risk of sudden cardiac death due to arrhythmias. According to the report published by the Coronary Artery Disease Foundation in 2022, around 356,000 out-of-hospital cardiac arrests (OHCA) are reported annually in the US. Lifestyle diseases, such as obesity, hypertension, dyslipidemia, and diabetes, are the major contributors to increasing the risk of development of various cardiovascular diseases. Moreover, the rising global geriatric population is another key factor contributing to the increasing prevalence of CVD. Aging is associated with an exponential rise in the development of Ventricular arrhythmias owing to the progressive deterioration and rise in the complexities in the structure and function of the heart resulting in a rising prevalence of arrhythmias in the aging population. All these factors are anticipated to propel the demand for defibrillators to provide the timely intervention of these devices during cardiac emergencies.

Restraint: Issues related to the use of implantable and automated external defibrillators

Public access defibrillators (or automated external defibrillators) are often found to be associated with technical issues such as battery defects or hardware defects. Similarly, faulty wiring, circuitry, and connectors are also reported frequently.

These defects often result in device failure to administer an electric shock in a timebound manner. Therefore, emergency care providers or public access facilities often prefer to adopt well-known brands with a proven track record of product quality while making a purchase decision. Thus, techno-commercial issues related to ICDs and AEDs are a major restraining factor for positive market growth of emerging vendors and local distributors worldwide.

Opportunity: Growing number of mergers & acquisitions among market players

Many key market players in the defibrillator market are increasingly acquiring other players to expand their product offerings globally. These acquisitions help manufacturers of implantable and external defibrillators improve their technical efficiencies, strengthen their financial base, penetrate emerging markets, and offer patients a wide range of products. Acquisitions enable defibrillator manufacturers to maintain their profit margins and enhance their geographic presence despite the increasing cost pressures. Some of the key mergers & acquisitions in the defibrillator market are listed below. In July 2020, ZOLL Medical (an Asahi Kasei subsidiary) acquired Cardiac Science to strengthen its Critical Care segment. This acquisition diversified the company's defibrillator and cardiac care segment, helping the parent company maintain a competitive edge in the market.

Challenge: Lack of awareness about sudden cardiac arrests in developing countries

Defibrillators are typically used to restore normal heartbeat in critical cardiac patients (such as arrhythmia, cardiac arrest, etc.). However, developing countries such as India, Indonesia, and Brazil are reported with limited public awareness levels about the clinical relevance of timely interventions through defibrillators as well as a limited operational understanding of defibrillators among the general public.

Therefore, clinical and product awareness level in developing countries is a major challenge to sustained and positive demand growth of defibrillator products during the coming decade. This is further aggravated by frequent product recalls resulting in lower availability of innovative external defibrillators in the market.

Defibrillator Market Ecosystem

Prominent companies in this market include financially stable and well-established manufacturers of defibrillator systems, reagents, gel documentation systems, and software. These companies have been operating in the market for several years and possess state-of-the-art technologies, diversified product portfolio, and strong marketing networks and global sales. Prominent companies in this market include Medtronic (Ireland), Stryker (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), MicroPort Scientific Corporation (China), NIHON KOHDEN CORPORATION (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), and Biotronik (Germany).

Defibrillators Market Ecosystem

Implantable cardioverter defibrillators (ICDs) segment to capture the largest share of the defibrillator industry during the forecast period

Based on product, the defibrillator market is segmented into Implantable Cardioverter Defibrillators and External Defibrillators. The implantable cardioverter defibrillator (ICDs) is further divided into Transvenous implantable cardioverter defibrillators and Subcutaneous implantable cardioverter defibrillators. In contrast, external defibrillators are divided into fully automated AED, manual AED, and wearable defibrillators. The ICDs segment dominated the global defibrillator market in 2022. This is attributed to technological advancements in ICDs, the growing preference of subcutaneous ICDs, and strong focus of players toward launching innovative ICDs. In May 2022, MicroPort Scientific Corporation (China)received marketing approval from the National Medical Products Administration of the People's Republic of China (NMPA) for its Platinum implantable cardioverter defibrillator across China.

In 2022, adult patients segment to dominate the defibrillator industry, by patient type.

Based on patient type, the defibrillator market is segmented into adult and pediatric patients. The adult patients segment dominated the global defibrillator market in 2022. Globally, an increased proportion of adult population suffering from cardiovascular diseases increases the risk of cardiac arrest. According to the data published by Sudden Cardiac Arrest Foundation in 2020, an estimated 347,322 adults in the US suffered from sudden cardiac arrest, which is anticipated to increase significantly in the coming years. Moreover, the rise in the geriatric patient population at higher risk of development of arrhythmias and growing awareness among adults about the accessibility of public access defibrillators are some of the key factors fueling the growth of the segment.

In 2022, North America to dominate in defibrillator industry

The global defibrillator market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate during the forecast period due to the advanced healthcare infrastructure, rapid adoption of innovative defibrillators, presence of key market players in the region, and availability of reimbursement for defibrillators surgical procedures.

Defibrillators Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The defibrillator market is dominated by players such as Medtronic (Ireland), Stryker (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), and Boston Scientific Corporation (US). Other players include Abbott (US), MicroPort Scientific Corporation (China), NIHON KOHDEN CORPORATION (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Biotronik (Germany), CU Medical Systems, Inc. (South Korea), METsis Medikal (Turkey), Mediana Co., Ltd (South Korea), Progetti srl (Italy), Schiller AG (Switzerland), BPL Medical Technologies (India), Metrax GmbH (Germany), MS Westfalia GmbH (Germany), Bexen Cardio (Spain), and Shenzhen Comen Medical Instruments Co., Ltd (China).

Scope of the Defibrillator Industry

Report Metric	Details
Market Revenue in 2023	$13.6 billion
Projected Revenue by 2028	$18.1 billion
Revenue Rate	Poised to grow at a CAGR of 5.9%
Market Driver	Growing prevalence of target diseases
Market Opportunity	Growing number of mergers & acquisitions among market players

This study categorizes the global defibrillator market to forecast revenue and analyze trends in each of the following submarkets:

By Type

Implantable cardioverter defibrillators
Transvenous implantable cardioverter defibrillators
Subcutaneous implantable cardioverter defibrillators
External defibrillators
Manual & semi-automated external defibrillators
Fully automated external defibrillators
Wearable cardioverter defibrillators

By Patients type

Adult
Pediatrics

By End Users

Hospitals, Clinics and Cardiac centres
Pre-hospital care settings
Public access markets
Home care settings
Alternate care facilities
Other end users

By Region

North America
- US
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe (RoE)
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- RoAPAC
Latin America
- Brazil
- Mexico
- RoLA
Middle East & Africa

Recent Developments of Defibrillator Industry

In February 2023, Medtronic (Ireland) received the CE Mark for its implantable defibrillator system, Aurora EV-ICD MRI SureScan, and Epsila EV MRI SureScan for the management of irregular heart rhythm.
In January 2022, Koninklijke Philips N.V. (Netherlands) acquired Cardiologs (France) to boost its cardiac diagnostic and monitoring product offerings.
In May 2021, MicroPort Scientific Corporation (China) and Implicitly Inc. (US) entered into a distribution agreement to scale up Microport's cardiac rhythm product offerings.

Frequently Asked Questions (FAQ):

What is the projected market revenue value of the defibrillator market?

The defibrillator market boasts a total revenue value of $18.1 billion by 2028.

What is the estimated growth rate (CAGR) of the defibrillator market?

The global defibrillator market has an estimated compound annual growth rate (CAGR) of 5.9% and a revenue size in the region of $13.6 billion in 2023.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 28)

1.1 STUDY OBJECTIVES

1.2 MARKET DEFINITION

1.2.1 INCLUSIONS AND EXCLUSIONS

1.3 STUDY SCOPE

FIGURE 1 MARKETS COVERED

1.3.1 GEOGRAPHIC SCOPE

1.3.2 YEARS CONSIDERED

1.4 CURRENCY CONSIDERED

1.5 STAKEHOLDERS

1.6 SUMMARY OF CHANGES

1.7 RECESSION IMPACT

2 RESEARCH METHODOLOGY (Page No. - 33)

2.1 RESEARCH DATA

FIGURE 2 RESEARCH DESIGN

2.1.1 SECONDARY DATA

2.1.2 PRIMARY RESEARCH

2.1.2.1 Key data from primary sources

FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS

FIGURE 4 DEFIBRILLATORS MARKET: BREAKDOWN OF PRIMARIES

2.2 MARKET SIZE ESTIMATION METHODOLOGY

FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING

2.2.1 PRODUCT-BASED MARKET ESTIMATION

2.2.2 END USER-BASED MARKET ESTIMATION

FIGURE 6 DEFIBRILLATORS MARKET: MARKET SIZE ESTIMATION

2.2.3 PRIMARY RESEARCH VALIDATION

2.3 DATA TRIANGULATION

FIGURE 7 DATA TRIANGULATION METHODOLOGY

2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS

2.4.1 RESEARCH ASSUMPTIONS

2.4.2 RESEARCH LIMITATIONS

2.5 RECESSION IMPACT

TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)

3 EXECUTIVE SUMMARY (Page No. - 43)

FIGURE 8 DEFIBRILLATORS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)

FIGURE 9 DEFIBRILLATORS MARKET, BY END USER, 2023 VS. 2028

FIGURE 10 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2023 VS. 2028

FIGURE 11 GEOGRAPHICAL SNAPSHOT OF DEFIBRILLATORS MARKET

4 PREMIUM INSIGHTS (Page No. - 46)

4.1 DEFIBRILLATORS MARKET OVERVIEW

FIGURE 12 RISING INCIDENCE OF CVD TO DRIVE MARKET

4.2 DEFIBRILLATORS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)

FIGURE 13 IMPLANTABLE DEFIBRILLATORS TO DOMINATE MARKET DURING FORECAST PERIOD

4.3 DEFIBRILLATORS MARKET, BY REGION AND END USER

FIGURE 14 HOSPITALS, CLINICS, AND CARDIAC CENTERS SEGMENT IN ASIA PACIFIC REGION ACCOUNTED FOR LARGEST SHARE IN 2022

4.4 GEOGRAPHIC SNAPSHOT OF DEFIBRILLATORS MARKET

FIGURE 15 CHINA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 50)

5.1 INTRODUCTION

5.2 MARKET DYNAMICS

FIGURE 16 DEFIBRILLATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES

5.2.1 DRIVERS

5.2.1.1 Rising prevalence of cardiovascular diseases

TABLE 2 PERCENTAGE OF POPULATION AGED 65 YEARS, BY REGION

5.2.1.2 Growing focus on providing public-access defibrillators

5.2.1.3 Training and awareness programs on defibrillators

5.2.2 RESTRAINTS

5.2.2.1 Frequent product recalls

TABLE 3 RECENT PRODUCT RECALLS BY US FDA (2018–2023)

5.2.3 OPPORTUNITIES

5.2.3.1 Emerging markets

5.2.3.2 Development of S-ICDs and MRI-compatible ICDs & CRT-Ds

5.2.4 CHALLENGES

5.2.4.1 Inadequate awareness of sudden cardiac arrests in emerging markets

5.2.4.2 Challenges associated with pricing pressure

5.3 REIMBURSEMENT SCENARIO

TABLE 4 MEDICAL REIMBURSEMENT CODES FOR DEFIBRILLATOR PROCEDURES IN US

TABLE 5 MEDICARE OUTPATIENT: NATIONAL AVERAGE PAYMENT IN US (2023)

5.4 REGULATORY LANDSCAPE

5.4.1 US

TABLE 6 US FDA: MEDICAL DEVICE CLASSIFICATION

TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS

5.4.1.1 Canada

TABLE 8 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS

5.4.2 EUROPE

5.4.3 ASIA PACIFIC

5.4.3.1 China

5.4.3.2 Japan

5.4.3.3 India

TABLE 9 KEY REGULATORY BODIES AND GOVERNMENT AGENCIES

5.5 PRICING TREND ANALYSIS

TABLE 10 AVERAGE SELLING PRICE OF DEFIBRILLATORS, BY KEY PLAYER (2021) (USD)

TABLE 11 AVERAGE SELLING PRICE OF DEFIBRILLATORS, BY COUNTRY (USD) (2021)

5.6 PATENT ANALYSIS

FIGURE 17 TOP PATENT APPLICANTS FOR DEFIBRILLATORS DEVICES, JANUARY 2012–MAY 2023

5.7 VALUE CHAIN ANALYSIS

5.7.1 RESEARCH & DEVELOPMENT

5.7.2 MANUFACTURING & ASSEMBLY

5.7.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES

FIGURE 18 DEFIBRILLATORS MARKET: VALUE CHAIN ANALYSIS

5.8 SUPPLY CHAIN ANALYSIS

FIGURE 19 AED MARKET: SUPPLY CHAIN ANALYSIS

5.9 PORTER’S FIVE FORCES ANALYSIS

5.9.1 OVERVIEW

TABLE 12 DEFIBRILLATORS MARKET: PORTER’S FIVE FORCES ANALYSIS

5.9.2 THREAT OF NEW ENTRANTS

5.9.3 THREAT OF SUBSTITUTES

5.9.4 BARGAINING POWER OF SUPPLIERS

5.9.5 BARGAINING POWER OF BUYERS

5.9.6 INTENSITY OF COMPETITIVE RIVALRY

5.10 TRADE ANALYSIS

TABLE 13 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION)

TABLE 14 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION)

5.11 TECHNOLOGY ANALYSIS

FIGURE 20 ECOSYSTEM COVERAGE

5.12 KEY CONFERENCES AND EVENTS

TABLE 15 AED MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2022−2023)

5.13 CASE STUDY ANALYSIS

5.13.1 IDENTIFY IMPACT OF 4-LAYER RIGID-FLEX BOARD PCB IN DEFIBRILLATORS

TABLE 16 CASE 1: IDENTIFY IMPACT OF THIN-LAYERED PCBS IN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS

5.14 STAKEHOLDERS AND BUYING CRITERIA

5.14.1 KEY STAKEHOLDERS

FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCTS

5.15 KEY BUYING CRITERIA

FIGURE 22 KEY BUYING CRITERIA FOR DEFIBRILLATORS

6 DEFIBRILLATORS MARKET, BY PRODUCT (Page No. - 72)

6.1 INTRODUCTION

TABLE 17 DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

6.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS

TABLE 18 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 19 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)

TABLE 20 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)

TABLE 21 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)

6.2.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS

TABLE 22 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 23 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)

6.2.1.1 Biventricular ICDs/Cardiac resynchronization therapy defibrillators

6.2.1.1.1 Launch of technologically advanced CRT-D devices to drive market

TABLE 24 BIVENTRICULAR ICDS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)

6.2.1.2 Dual-chamber ICDs

6.2.1.2.1 Ability to reduce incidence of inappropriate shocks to drive market

TABLE 25 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)

6.2.1.3 Single-chamber ICDs

6.2.1.3.1 Utilization in arterial monitoring to support market growth

TABLE 26 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)

6.2.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS

6.2.2.1 Benefits of eliminating cardiac leads to drive market

TABLE 27 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)

6.3 EXTERNAL DEFIBRILLATORS

TABLE 28 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 29 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)

TABLE 30 EXTERNAL DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)

TABLE 31 EXTERNAL DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)

6.3.1 SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS

6.3.1.1 Initiatives for emergency medical services to support market growth

TABLE32 SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)

6.3.2 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS

6.3.2.1 Rising installation in public places to propel market

TABLE33 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)

6.3.3 WEARABLE CARDIOVERTER DEFIBRILLATORS

6.3.3.1 Operational difficulties and false alarms to restrain market adoption

TABLE34 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)

7 DEFIBRILLATOR MARKET, BY PATIENT TYPE (Page No. - 85)

7.1 INTRODUCTION

TABLE 35 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)

7.2 ADULT PATIENTS

7.2.1 INCREASING UTILIZATION OF PUBLIC-ACCESS DEFIBRILLATORS TO DRIVE MARKET

TABLE 36 AED MARKET FOR ADULT PATIENTS, BY REGION, 2021–2028 (USD MILLION)

7.3 PEDIATRIC PATIENTS

7.3.1 INCREASING INCIDENCE OF PEDIATRIC HEART AILMENTS TO SUPPORT MARKET GROWTH

TABLE 37 DEFIBRILLATORS MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2021–2028 (USD MILLION)

8 DEFIBRILLATOR MARKET, BY END USER (Page No. - 89)

8.1 INTRODUCTION

TABLE 38 DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)

8.2 HOSPITALS, CLINICS, AND CARDIAC CENTERS

8.2.1 HIGH VOLUME OF ICD PROCEDURES TO DRIVE MARKET

TABLE 39 AED MARKET FOR HOSPITALS, CLINICS, AND CARDIAC CENTERS, BY REGION, 2021–2028 (USD MILLION)

8.3 PREHOSPITAL SETTINGS

8.3.1 RISING FUNDING FOR EMERGENCY AMBULANCE SERVICES TO DRIVE MARKET

TABLE 40 DEFIBRILLATORS MARKET FOR PREHOSPITAL SETTINGS, BY REGION, 2021–2028 (USD MILLION)

8.4 PUBLIC-ACCESS MARKETS

8.4.1 RISING INCIDENCE OF SUDDEN CARDIAC ARRESTS TO PROPEL MARKET

TABLE 41 AED MARKET FOR PUBLIC-ACCESS MARKETS, BY REGION, 2021–2028 (USD MILLION)

8.5 HOME CARE SETTINGS

8.5.1 RISING ADOPTION OF HOME-AUTOMATED EXTERNAL DEFIBRILLATORS TO DRIVE MARKET

TABLE 42 DEFIBRILLATORS MARKET FOR HOME CARE SETTINGS, BY REGION, 2021–2028 (USD MILLION)

8.6 ALTERNATE CARE FACILITIES

8.6.1 INADEQUATE HEALTHCARE INFRASTRUCTURE TO LIMIT ADOPTION

TABLE 43 AED MARKET FOR ALTERNATE CARE FACILITIES, BY REGION, 2021–2028 (USD MILLION)

8.7 OTHER END USERS

TABLE 44 DEFIBRILLATORS MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)

9 DEFIBRILLATOR MARKET, BY REGION (Page No. - 96)

9.1 INTRODUCTION

TABLE 45 DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)

9.2 NORTH AMERICA

FIGURE 23 NORTH AMERICA: DEFIBRILLATORS MARKET SNAPSHOT

TABLE 46 NORTH AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)

TABLE 47 NORTH AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 48 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 49 NORTH AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 50 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 51 NORTH AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)

TABLE 52 NORTH AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)

9.2.1 US

9.2.1.1 High implant rates of ICDS to drive market

TABLE53 US: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE54 US: IMPLANTABLECARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE55 US: TRANSVENOUS IMPLANTABLECARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE56 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

9.2.2 CANADA

9.2.2.1 High burden of CVDs to support market growth

TABLE57 CANADA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE58 CANADA: IMPLANTABLECARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE59 CANADA: TRANSVENOUS IMPLANTABLECARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE60 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

9.2.3 NORTH AMERICA: RECESSION IMPACT

9.3 EUROPE

TABLE 61 EUROPE: DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)

TABLE 62 EUROPE: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 63 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 64 EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 65 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 66 EUROPE: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)

TABLE 67 EUROPE: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)

9.3.1 GERMANY

9.3.1.1 Established healthcare system equipped with advanced cardiology devices to drive market

TABLE68 GERMANY: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE69 GERMANY: IMPLANTABLECARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE70 GERMANY: TRANSVENOUS IMPLANTABLECARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE71 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

9.3.2 UK

9.3.2.1 Rising support from government & private organizations for accessibility of defibrillators to drive market

TABLE72 UK: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE73 UK: IMPLANTABLECARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE74 UK: TRANSVENOUS IMPLANTABLECARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 USD MILLION)

TABLE75 UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

9.3.3 FRANCE

9.3.3.1 Favorable government initiatives to support market growth

TABLE76 FRANCE: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE77 FRANCE: IMPLANTABLECARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE78 FRANCE: TRANSVENOUS IMPLANTABLECARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE79 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

9.3.4 ITALY

9.3.4.1 High prevalence of OHCA to drive market

TABLE80 ITALY: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE81 ITALY: IMPLANTABLECARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE82 ITALY: TRANSVENOUS IMPLANTABLECARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE83 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

9.3.5 SPAIN

9.3.5.1 Rising awareness initiatives on defibrillators to propel market

TABLE84 SPAIN: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE85 SPAIN: IMPLANTABLECARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE86 SPAIN: TRANSVENOUS IMPLANTABLECARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE87 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

9.3.6 REST OF EUROPE

TABLE 88 REST OF EUROPE: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 89 REST OF EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 90 REST OF EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 91 REST OF EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

9.3.7 EUROPE: RECESSION IMPACT

9.4 ASIA PACIFIC

FIGURE 24 ASIA PACIFIC: DEFIBRILLATORS MARKET SNAPSHOT

TABLE 92 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)

TABLE 93 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 94 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 95 ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 96 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 97 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)

TABLE 98 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)

9.4.1 JAPAN

9.4.1.1 Presence of universal insurance scheme in Japan to support market growth

TABLE 99 JAPAN: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 100 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 101 JAPAN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 102 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

9.4.2 CHINA

9.4.2.1 Rising incidence of strokes to drive market

TABLE 103 CHINA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 104 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 105 CHINA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 106 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

9.4.3 INDIA

9.4.3.1 Growing acceptance of defibrillators and innovative product launches to drive market

TABLE 107 INDIA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 108 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 109 INDIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 110 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

9.4.4 AUSTRALIA

9.4.4.1 Initiatives by government & private bodies for installation of PADs to support market growth

TABLE 111 AUSTRALIA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 112 AUSTRALIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 113 AUSTRALIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 114 AUSTRALIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

9.4.5 SOUTH KOREA

9.4.5.1 Launch of innovative products by local players to propel market

TABLE 115 SOUTH KOREA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 116 SOUTH KOREA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 117 SOUTH KOREA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 118 SOUTH KOREA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

9.4.6 REST OF ASIA PACIFIC (ROAPAC)

TABLE 119 REST OF ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 120 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 121 REST OF ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 122 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

9.4.7 ASIA PACIFIC: RECESSION IMPACT

9.5 LATIN AMERICA

TABLE 123 LATIN AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)

TABLE 124 LATIN AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 125 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 126 LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 127 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 128 LATIN AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)

TABLE 129 LATIN AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)

9.5.1 BRAZIL

9.5.1.1 Increasing obesity cases to support market growth

TABLE 130 BRAZIL: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 131 BRAZIL: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 132 BRAZIL: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 133 BRAZIL: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

9.5.2 MEXICO

9.5.2.1 High prevalence of target diseases to support market growth

TABLE 134 MEXICO: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 135 MEXICO: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 136 MEXICO: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 137 MEXICO: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

9.5.3 REST OF LATIN AMERICA

TABLE 138 REST OF LATIN AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 139 REST OF LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 140 REST OF LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 141 REST OF LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

9.5.4 LATIN AMERICA: RECESSION IMPACT

9.6 MIDDLE EAST & AFRICA

9.6.1 GROWING AWARENESS INITIATIVES ON ADVANTAGES OF DEFIBRILLATORS TO SUPPORT MARKET GROWTH

TABLE 142 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)

TABLE 143 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 144 MIDDLE EAST & AFRICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 145 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)

TABLE 146 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)

TABLE 147 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)

9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT

10 COMPETITIVE LANDSCAPE (Page No. - 145)

10.1 INTRODUCTION

10.1.1 STRATEGIES ADOPTED BY KEY PLAYERS

TABLE 148 STRATEGIES ADOPTED BY KEY PLAYERS (2019−2023)

10.2 REVENUE SHARE ANALYSIS

FIGURE 25 DEFIBRILLATORS MARKET: REVENUE SHARE ANALYSIS OF PLAYERS

10.3 MARKET SHARE ANALYSIS

FIGURE 26 AED MARKET SHARE, BY KEY PLAYER (2022)

TABLE 149 IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (ICD) MARKET: INTENSITY OF COMPETITIVE RIVALRY

TABLE 150 AUTOMATED DEFIBRILLATORS MARKET: INTENSITY OF COMPETITIVE RIVALRY

10.4 AED MARKET: COMPANY EVALUATION MATRIX (2022)

10.4.1 STARS

10.4.2 EMERGING LEADERS

10.4.3 PERVASIVE PLAYERS

10.4.4 PARTICIPANTS

FIGURE 27 DEFIBRILLATORS MARKET: COMPANY EVALUATION MATRIX (2022)

10.5 AED MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)

10.5.1 PROGRESSIVE COMPANIES

10.5.2 RESPONSIVE COMPANIES

10.5.3 DYNAMIC COMPANIES

10.5.4 STARTING BLOCKS

FIGURE 28 DEFIBRILLATORS MARKET: COMPANY EVALUATION MATRIX FOR SMES/STARTUPS (2022)

10.6 COMPETITIVE BENCHMARKING: FOOTPRINT ANALYSIS OF LEADING PLAYERS

TABLE 151 AED MARKET: COMPANY FOOTPRINT ANALYSIS

TABLE 152 DEFIBRILLATORS MARKET: PRODUCT FOOTPRINT ANALYSIS

TABLE 153 AED MARKET: REGIONAL FOOTPRINT ANALYSIS

10.6.1 PRODUCT LAUNCHES & APPROVALS

TABLE 154 DEFIBRILLATORS MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2019–APRIL 2023)

10.6.2 DEALS

TABLE 155 AED MARKET: KEY DEALS (JANUARY 2019–APRIL 2023)

10.6.3 OTHER DEVELOPMENTS

TABLE 156 AED MARKET: OTHER DEVELOPMENTS (JANUARY 2019–APRIL 2023)

11 COMPANY PROFILES (Page No. - 159)

11.1 KEY PLAYERS

(Business Overview, Products Offered, Recent Developments, and MnM View)*

11.1.1 MEDTRONIC

TABLE 157 MEDTRONIC: BUSINESS OVERVIEW

FIGURE 29 MEDTRONIC: COMPANY SNAPSHOT (2022)

11.1.2 STRYKER

TABLE 158 STRYKER: BUSINESS OVERVIEW

FIGURE 30 STRYKER: COMPANY SNAPSHOT (2022)

11.1.3 KONINKLIJKE PHILIPS N.V.

TABLE 159 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW

FIGURE 31 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)

11.1.4 ASAHI KASEI CORPORATION

TABLE 160 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW

FIGURE 32 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2022)

11.1.5 BOSTON SCIENTIFIC CORPORATION

TABLE 161 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW

FIGURE 33 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)

11.1.6 ABBOTT

TABLE 162 ABBOTT: BUSINESS OVERVIEW

FIGURE 34 ABBOTT: COMPANY SNAPSHOT (2022)

TABLE 163 PRODUCT APPROVALS

11.1.7 MICROPORT SCIENTIFIC CORPORATION

TABLE 164 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW

FIGURE 35 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)

TABLE 165 PRODUCT APPROVALS

11.1.8 NIHON KOHDEN CORPORATION

TABLE 166 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW

FIGURE 36 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022)

11.1.9 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

TABLE 167 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: BUSINESS OVERVIEW

FIGURE 37 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2021)

TABLE 168 PRODUCT LAUNCHES & APPROVALS

11.1.10 BIOTRONIK

TABLE 169 BIOTRONIK: BUSINESS OVERVIEW

11.1.11 CU MEDICAL SYSTEMS CO., LTD.

TABLE 170 CU MEDICAL SYSTEMS CO., LTD.: BUSINESS OVERVIEW

11.1.12 METSIS MEDIKAL LTD.

TABLE 171 METSIS MEDIKAL LTD: BUSINESS OVERVIEW

11.1.13 MEDIANA CO. LTD.

TABLE 172 MEDIANA CO. LTD.: BUSINESS OVERVIEW

11.1.14 PROGETTI SRL

TABLE 173 PROGETTI SRL: BUSINESS OVERVIEW

11.1.15 SCHILLER AG

TABLE 174 SCHILLER AG: BUSINESS OVERVIEW

11.1.16 BPL MEDICAL TECHNOLOGIES

TABLE 175 BPL MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW

11.1.17 METRAX GMBH

TABLE 176 METRAX GMBH: BUSINESS OVERVIEW

11.1.18 MS WESTFALIA GMBH

TABLE 177 MS WESTFALIA GMBH: BUSINESS OVERVIEW

11.1.19 BEXEN CARDIO

TABLE 178 BEXEN CARDIO: BUSINESS OVERVIEW

11.1.20 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.

TABLE 179 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.: BUSINESS OVERVIEW

* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

11.2 OTHER PLAYERS

11.2.1 AVIVE SOLUTIONS INC.

11.2.2 AMI ITALIA

11.2.3 CORPULS

11.2.4 ALLIED MEDICAL LTD.

11.2.5 AXION CONCERN LLC

12 APPENDIX (Page No. - 210)

12.1 DISCUSSION GUIDE

12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL

12.3 CUSTOMIZATION OPTIONS

12.4 RELATED REPORTS

12.5 AUTHOR DETAILS

The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the defibrillator market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. Market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Collecting Secondary Data

The secondary research data collection process involves the usage of secondary sources, directories, and databases (such as World Health Organization (WHO), World Bank, Organisation for Economic Co-operation and Development (OECD), American Heart Association (AHA), American Society For Preventive Cardiology (ASPC), World Heart Federation (WHF), Centers for Disease Control and Prevention (CDC), US Food and Drug Association (FDA) National Institutes of Health (NIH), annual reports, investor presentations, and SEC filings of companies). Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the defibrillator market. A database of the key industry leaders was also prepared using secondary research.

Collecting Primary Data

The primary research data was conducted through secondary research after acquiring knowledge about the defibrillator market scenario. A significant number of primary interviews were conducted with stakeholders from both the demand side (hospitals, clinics, cardiac centers, prehospital emergency care centers) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America.

Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Breakdown of Primary Participants:

Defibrillators Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Global Defibrillator Market Size: Bottom-Up Approach

Defibrillators Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Defibrillator Market Size: Bottom-Up Approach

Defibrillators Market Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the defibrillators industry.

Market Definition

A defibrillator is a device that monitors the heart rhythm and delivers electric shocks upon detecting an abnormal heart rhythm to restore the normal heart rhythm. The device plays an important role in the management and treatment of sudden cardiac arrest.

Key Stakeholders

Manufacturers of defibrillators
Distributors of defibrillators
Hospitals, Clinics, Cardiac Centers
Non-government organizations
Government regulatory authorities
Contract manufacturers and third-party suppliers
Research laboratories and academic institutes
Clinical research organizations (CROs)
Government and non-governmental regulatory authorities

Report Objectives

To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
To define, describe, segment, and forecast the defibrillator market by product, patient type, end user, and region
To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall defibrillator market
To forecast the size of the defibrillator market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
To profile key players in the defibrillator market and comprehensively analyze their core competencies and market shares
To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the defibrillator market
To benchmark players within the defibrillator market using the competitive leadership mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

MarketsandMarkets offers the following customizations for this market report:

Additional country-level analysis of the Defibrillator market
Profiling of additional market players (up to 5)

Product Analysis

Product matrix, which provides a detailed comparison of the product portfolio of each company in the Defibrillator Market

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.